The role of ADRB2 gene polymorphisms in malignancies

被引：13

作者：

Wang, Yaqian ^{[1
]}

Jiang, Shujuan ^{[1
,2
,3
]}

机构：

[1] Shandong Univ, Shandong Prov Hosp, Cheeloo Coll Med, Dept Resp & Crit Care Med, Jingwu Rd 324, Jinan 250021, Shandong, Peoples R China

[2] Shandong First Med Univ, Shandong Prov Hosp, Dept Resp & Crit Care Med, Jinan 250021, Shandong, Peoples R China

[3] Shandong Key Lab Infect Resp Dis, Jinan 250021, Shandong, Peoples R China

来源：

MOLECULAR BIOLOGY REPORTS | 2021年 / 48卷 / 03期

关键词：

ADRB2; Malignancy; Single nucleotide polymorphism; β (2)-Adrenergic receptor; BETA-2-ADRENERGIC RECEPTOR GENE; CELL LUNG-CANCER; SINGLE NUCLEOTIDE POLYMORPHISMS; 5' LEADER CISTRON; BETA-BLOCKERS; BREAST-CANCER; PROMOTER POLYMORPHISMS; ANTAGONIST PROPRANOLOL; SMOOTH-MUSCLE; KAPPA-B;

D O I：

10.1007/s11033-021-06250-y

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Beta-2-adrenergic receptor is a member of the G protein-coupled receptor superfamily, which is highly expressed in most malignancies. There is increasing evidence showing that beta-2-adrenergic receptors are associated with carcinogenesis, proliferation, immune regulation, invasion, angiogenesis, clinical prognosis and treatment resistance in malignancies. Polymorphisms of the ADRB2 gene have been confirmed to be associated with transcriptional activity, mRNA translation, and beta-2-adrenergic receptor expression and sensitivity. This review discusses clinically relevant examples of single nucleotide polymorphisms of ADRB2 in malignancies and the effects of these polymorphisms on cancer susceptibility, prognosis and treatment response of cancer patients.

引用

页码：2741 / 2749

页数：9

共 50 条

[31] ADRB2 Gene Polymorphism in Children with Bronchial Asthma
Telepneva, R.
Evseeva, G.
Nagovitsyna, E.
Suprun, E.
Suprun, S.
Lebedko, O.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
[32] A pharmacogenetic study of ADRB2 polymorphisms and indacaterol response in COPD patients
R Yelensky
Y Li
S Lewitzky
E Leroy
C Hurwitz
D Rodman
A Trifilieff
C A Paulding
The Pharmacogenomics Journal, 2012, 12 : 484 - 488
[33] The Role of ADRB2 in Myasthenia: Genetic and Immunological Factors
Lantsova, V. B.
Gerasimov, A. S.
Sepp, E. K.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2013, 154 (03) : 351 - 353
[34] Role of ADRB2 gene polymorphism in asthma and response to β2-agonists in Polish children
Szczepankiewicz, A.
Breborowicz, A.
Sobkowiak, P.
Kramer, L.
Popiel, A.
JOURNAL OF APPLIED GENETICS, 2009, 50 (03) : 275 - 281
[35] RELATIONSHIP BETWEEN FABP2, PPARG, ADRB2 AND ADRB3 GENE POLYMORPHISMS PREDICTING THE RISK OF DEVELOPING TYPE 2 DIABETES
Komir, I. R.
Isayeva, A. S.
Vovchenko, M. M.
Yemelianova, N. Y.
ATHEROSCLEROSIS, 2021, 331 : E223 - E223
[36] Genetic Determinants of Cardiovascular Reactions in Humans with Different Polymorphisms of the ADRB2 Gene in Response to the Diving Reflex
Podyacheva, Ekaterina
Baranova, Tatyana
FASEB JOURNAL, 2021, 35
[37] A pharmacogenetic study of ADRB2 polymorphisms and indacaterol response in COPD patients
Yelensky, R.
Li, Y.
Lewitzky, S.
Leroy, E.
Hurwitz, C.
Rodman, D.
Trifilieff, A.
Paulding, C. A.
PHARMACOGENOMICS JOURNAL, 2012, 12 (06): : 484 - 488
[38] The Role of Polymorphisms in the ACE and ADRB2 Genes in Incidence of Myocardial Infarction in Framingham Heart Study Participants
Kulminski, Alexander
Ukraintseva, Svetlana
Culminskaya, Irina
Arbeev, Konstantin
Akushevich, Igor
Yashin, Anatoli
GENETIC EPIDEMIOLOGY, 2009, 33 (08) : 824 - 824
[39] Associations of Polymorphisms in the ADRB1 and ADRB2 Genes and Response to Timolol and Betaxolol in Glaucoma Patients
Sabato, M.
Leffler, C.
Wilkinson, D.
Gonzalez, A. Ferreira
JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (06): : 866 - 866
[40] Genetic mapping of the ADRB2 gene on cattle chromosome 7
Schimpf, RJ
Schmutz, SM
Buchanan, FC
ANIMAL GENETICS, 2001, 32 (06) : 390 - 390

← 1 2 3 4 5 →